Anika Therapeutics, Inc. 4
4 · Anika Therapeutics, Inc. · Filed Jan 28, 2016
Insider Transaction Report
Form 4
WHEELER STEVE E
Director
Transactions
- Exercise/Conversion
Stock Appreciation Right
2016-01-26−1,770→ 0 totalExercise: $10.51Exp: 2016-01-26→ Common Stock (1,770 underlying) - Exercise/Conversion
Common Stock
2016-01-26$10.51/sh+1,770$18,603→ 31,122 total - Tax Payment
Common Stock
2016-01-26$38.33/sh−486$18,628→ 30,636 total
Footnotes (2)
- [F1]Exercise of stock appreciation rights ("SARs") granted on January 26, 2006, which vested in full immediately on such date, and expiring on January 26, 2016.
- [F2]Reflects 486 shares of common stock utilized to cover the exercise price of the above listed SARs award by the Reporting Person on January 26, 2016.